• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    IDEAYA Biosciences, Inc. - Common Stock (NQ: IDYA )

    25.61 +0.82 (+3.31%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,021,014
    Open 24.57
    Bid (Size) 25.40 (1)
    Ask (Size) 27.00 (2)
    Prev. Close 24.79
    Today's Range 24.51 - 26.49
    52wk Range 24.48 - 47.73
    Shares Outstanding 48,390,394
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
    Altria Group is "undervalued," Cramer says. On Oct. 31, the company reported third-quarter adjusted earnings per share of $1.38. 
    Via Benzinga
    Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
    From Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
    Via Business Wire

    Performance

    YTD
    -27.29%
    -27.29%
    1 Month
    -3.72%
    -3.72%
    3 Month
    -24.07%
    -24.07%
    6 Month
    -30.78%
    -30.78%
    1 Year
    -26.11%
    -26.11%

    More News

    Read More
    This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
    Via Benzinga
    Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate
    Via Benzinga
    Unveiling 5 Analyst Insights On IDEAYA Biosciences
    Via Benzinga
    Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews
    Via Benzinga
    The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts
    Via Benzinga
    Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q2 2024
    Via InvestorPlace
    Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal
    Via Talk Markets
    MarketBeat Week in Review – 7/15 - 7/19
    Via MarketBeat
    Topics Economy
    Exposures Interest Rates
    Positive News is Driving This Cancer Drug Maker’s Stock Higher
    Via MarketBeat
    Recap: IDEAYA Biosciences Q4 Earnings
    Via Benzinga
    The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts
    Via Benzinga
    Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer
    Via Benzinga
    Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Why Ideaya Biosciences Just Made Its Most Bullish Move Since March
    Via Investor's Business Daily
    Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/24
    Via Investor Brand Network
    IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/19
    Via Investor Brand Network
    IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q1 2024
    Via InvestorPlace
    Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.